NYSE: UNHUnitedhealth Group Inc Stock
$486.05-6.43 (-1.31%)
Updated Jan 27, 2023
UNH Price
$486.05
Fair Value Price
N/A
Market Cap
$454.14B
52 Week Low
$436.51
52 Week High
$558.10
P/E
23.47x
P/B
6.08x
P/S
1.5x
PEG
1.51x
Dividend Yield
1.32%
Revenue
$315.12B
Earnings
$19.43B
Gross Margin
24.2%
Operating Margin
8.44%
Profit Margin
6.2%
Debt to Equity
2.15
Operating Cash Flow
$34B
Beta
0.91
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
UNH Overview
UnitedHealth Group Incorporated offers health benefit plans and services for employers, public sector employers, small businesses, and individuals. Its OptumHealth segment provides access to networks of specialists, health management services, and financial services. OptumInsight offers software products, consulting, and outsourcing to hospitals, physicians, and related organizations. OptumRx provides pharmacy services and programs. The company was incorporated in 1977 and is based in Minnetonka, MN.
Zen Score
–
Industry Average (39)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how UNH scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
UNH ($486.05) is trading above its intrinsic value of $240.75, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
UNH is good value based on its earnings relative to its share price (23.47x), compared to the US market average (23.59x)
P/E vs Market Valuation
UNH is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more UNH due diligence checks available for Premium users.
Be the first to know about important UNH news, forecast changes, insider trades & much more!
UNH News
Valuation
UNH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
23.47x
Industry
23.22x
Market
23.59x
UNH is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
UNH is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
UNH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
6.08x
Industry
3.29x
UNH is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
UNH price to earnings growth (PEG)
For valuing profitable companies with growth potential
UNH is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
UNH's financial health
Profit margin
Revenue
$80.9B
Net Income
$5.3B
Profit Margin
6.5%
UNH's Earnings (EBIT) of $26.59B... subscribe to Premium to read more.
Interest Coverage Financials
UNH's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$243.1B
Liabilities
$160.1B
Debt to equity
2.15
UNH's short-term liabilities ($100.94B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
UNH's short-term assets ($82.94B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
UNH's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
UNH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$18.5B
Investing
-$847.0M
Financing
-$3.4B
UNH's operating cash flow ($33.96B)... subscribe to Premium to read more.
Debt Coverage Financials
UNH vs Healthcare Plan Stocks
Unitedhealth Group Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.